Send feedback

CABP2 p.Gly170=

c.510C>T · rs114668091 · VCV713351

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
rare (popmax 0.195%, afr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2.4GERP -2.8, phastCons 1
Overall
CADD9.553PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.195% African / African-American · 146/75,020 alleles
Filtering AF 0.169% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.159%
Overall 0.0103% 166/1,609,714 alleles · rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.195% 514
Admixed American 0.0234% 4,283
Remaining individualsnot grpmax-eligible 0.00961% 10,408

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CABP2
Protein
p.Gly170=
Coding
c.510C>T
MANE Select
NM_016366
dbSNP
rs114668091
Type
single nucleotide variant
Location
chr11:67519920 (GRCh38)
Gene constraint
LOEUF 1.299 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 68.93
Residue 170
a UniProt-annotated variant site (in dfnb93); the ef-hand 3 domain
Full CABP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cabp2-p-gly170 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown